We observed equivalent effects in a subset of mobile traces treated with bardoxolone methyl (S10 Fig)
This is consistent with the proven mechanism of action of the AIMs--direct binding to KEAP1 C151 blocks NRF2 degradation and benefits in its accumulation and activation as a transcription factor…